Omega Therapeutics, Inc.

OMGACIK 0001850838 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 28, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0130Δ-0.00496% similar+1779/-11 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Feb 24, 2025no items parsed Feb 14, 2025no items parsed Feb 3, 2025no items parsed Jan 28, 2025no items parsed Jan 17, 2025no items parsed

YoY shift: Lean -

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.49pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Omega Therapeutics, Inc.

Name	Roles	Filings
Mendlein John	Director	3
McCauley Thomas	Officer	3
Moore Yan	Officer	3
Reed Joshua	Officer	3
Szela Mary T	Director	3

Showing 6-10 of 24

Per pagePrevPage 2 of 5Next

All filings

55 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 21, 2024	Boehm Rainer J. Director	Holdings only	-	-	-
Jun 21, 2024	Szela Mary T Director	Holdings only	-	-	-
May 31, 2024	Certel Kaan Chief Business Officer	Holdings only	-	-	-
Feb 9, 2024	Zeng Ling See Remarks	Holdings only	-	-	-
Feb 9, 2024	Schade Christian S Director	Holdings only	-	-	-

Showing 11-15 of 55

Per pagePrevPage 3 of 11Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value